Antibodies in Mothers of Children with Neonatal Lupus
Author Information
Author(s): Christine Fritsch, Johan Hoebeke, Hayet Dali, Vincent Ricchiuti, David A Isenberg, Olivier Meyer, Sylviane Muller
Primary Institution: Centre National de la Recherche Scientifique, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France
Hypothesis
The study aims to identify Ro52/60-kDa Ro/SSA antigen epitopes associated with neonatal lupus and congenital heart block.
Conclusion
Mothers with lupus whose children have neonatal lupus show higher levels of specific antibodies during pregnancy, which may predict complications.
Supporting Evidence
- Significant differences in antibody levels were observed between lupus mothers with affected children and those with healthy children.
- Elevated levels of antibodies were found during the critical period of gestation between 18 and 30 weeks.
- Antibodies to specific Ro52 peptides may serve as biomarkers for predicting complications in pregnancies.
Takeaway
Some mothers have special proteins in their blood that can affect their babies' hearts. This study looks for those proteins to help keep babies safe.
Methodology
The study tested the sera from 66 mothers using ELISA to measure antibodies against Ro52, Ro60, and La proteins, as well as synthetic peptides.
Potential Biases
Potential bias in selecting control groups and the retrospective nature of some data collection.
Limitations
The study's findings may not be generalizable due to the specific population studied and the relatively small sample size.
Participant Demographics
Mothers aged 19-56 years, with varying autoimmune conditions including systemic lupus erythematosus and Sjögren's syndrome.
Statistical Information
P-Value
0.023 for Ro52 peptide 107–122
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website